US companies collaborate on wound management:
This article was originally published in Clinica
Executive Summary
US wound management companies FibroGen and ZymoGenetics have agreed to work together on a new range of tissue sealant products. ZymoGenetics, of Seattle, Washington, will combine its recombinant thrombin with the recombinant type III collagen developed by FibroGen, of South San Francisco.